TrialJournal of neurology, neurosurgery, and psychiatry2017

Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial.

Satoshi Kuwabara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.